Anti-Human EGFR Recombinant Antibody(Nimotuzumab)

Product Information

Catalog Number	YR1033
Product Name	Anti-Human EGFR Recombinant Antibody(Nimotuzumab)
Molecular Name	Nimotuzumab
Alias	Anti-EGFR Recombinant Antibody, Research Grade Nimotuzumab
CAS Number	828933-51-3
Molecular Weight	148 kDa
Target	EGFR[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, IP, FCM, FuncS, Neut, IF, IHC
Buffer	PBS, pH7.5
Background	Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India, TheraCIM, CIMYM Biosciences, Canada, Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price